Expert Opinion on Investigational Drugs : Impact Factor & More
eISSN: 1744-7658pISSN: 1354-3784
Share this on:
Aims and Scope of Expert Opinion on Investigational Drugs
Expert Opinion on Investigational Drugs is a monthly peer-reviewed medical journal covering developments in pharmaceutical research, from animal studies through to early clinical investigation. The journal's scope includes therapeutics in many areas: pulmonary-allergy, dermatology, gastrointestinal, arthritis, infectious disorders, endocrine and metabolic, central and peripheral nervous system, cardiovascular and renal, and oncology. Less
Key Metrics
CiteScore 
8.6
H-Index
114
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.06
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Expert Opinion on Investigational Drugs
Expert Opinion on Investigational Drugs Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Investigational Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Investigational Drugs
Discontinued therapies for sickle cell disease: status and future directions
- 25 Apr 2026
- Expert Opinion on Investigational Drugs
Targeting cutaneous T-cell lymphoma in non-Hodgkin lymphoma: what’s new for investigational agents?
- 23 Apr 2026
- Expert Opinion on Investigational Drugs
Tafoxiparin effects on cervical ripening and labor augmentation
- 22 Apr 2026
- Expert Opinion on Investigational Drugs
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma
- 18 Apr 2026
- Expert Opinion on Investigational Drugs
ANGPTL3 gene editing with CRISPR-Cas9: early trial insights
- 12 Apr 2026
- Expert Opinion on Investigational Drugs
Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia
- 3 Apr 2026
- Expert Opinion on Investigational Drugs
Discontinued therapies for sickle cell disease: status and future directions
- 25 Apr 2026
- Expert Opinion on Investigational Drugs
Targeting cutaneous T-cell lymphoma in non-Hodgkin lymphoma: what’s new for investigational agents?
- 23 Apr 2026
- Expert Opinion on Investigational Drugs
Tafoxiparin effects on cervical ripening and labor augmentation
- 22 Apr 2026
- Expert Opinion on Investigational Drugs
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma
- 18 Apr 2026
- Expert Opinion on Investigational Drugs
ANGPTL3 gene editing with CRISPR-Cas9: early trial insights
- 12 Apr 2026
- Expert Opinion on Investigational Drugs
Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia
- 3 Apr 2026
- Expert Opinion on Investigational Drugs
FAQs on Expert Opinion on Investigational Drugs
How long has Expert Opinion on Investigational Drugs been actively publishing? 
What is the publishing frequency of Expert Opinion on Investigational Drugs?
How many articles did Expert Opinion on Investigational Drugs publish last year?
What is the eISSN & pISSN for Expert Opinion on Investigational Drugs?
What is Citescore for Expert Opinion on Investigational Drugs?
What is the H Index for Expert Opinion on Investigational Drugs ?
What is SNIP score for Expert Opinion on Investigational Drugs?
What is the SJR for Expert Opinion on Investigational Drugs?
Who is the publisher of Expert Opinion on Investigational Drugs?
